APLT - Applied Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

452.8M

Cash

49.9M

Avg Qtr Burn

-13.79M

Short % of Float

5.86%

Insider Ownership

7.18%

Institutional Own.

69.56%

Qtr Updated

12/31/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Govorestat (AT-007) Details Galactosemia, Rare diseases, Rare genetic disease Big Mover™ Suspected Mover™ Susp. Mover™	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Govorestat (AT-007) Details Sorbitol dehydrogenase deficiency	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Caficrestat (AT-001) Details Hemophilia, Genetic disorder, Diabetic cardiomyopathy	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Govorestat (AT-007) Details Phosphomannomutase 2 deficiency , Congenital disorder of glycosylation	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AT-003 Details Diabetic retinopathy	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AT-104 Details Leukemia, B-cell acute lymphoblastic leukemia, T-cell lymphoma	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.